Article Versions Notes

Schino I, Cantore M, de Candia M, Altomare CD, Maria C, Barros J, Cachatra V, Calado P, Shimizu K, Freitas AA, et al. Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease. Pharmaceuticals. 2023; 16(1):54. https://doi.org/10.3390/ph16010054

Schino, Ignazio, Mariangela Cantore, Modesto de Candia, Cosimo D. Altomare, Catarina Maria, João Barros, Vasco Cachatra, Patrícia Calado, Karina Shimizu, Adilson A. Freitas, and et al. 2023. "Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease" Pharmaceuticals 16, no. 1: 54. https://doi.org/10.3390/ph16010054

Schino, I., Cantore, M., de Candia, M., Altomare, C. D., Maria, C., Barros, J., Cachatra, V., Calado, P., Shimizu, K., Freitas, A. A., Oliveira, M. C., Ferreira, M. J., Lopes, J. N. C., Colabufo, N. A., & Rauter, A. P. (2023). Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease. Pharmaceuticals, 16(1), 54. https://doi.org/10.3390/ph16010054